IBB ETF holdings (NASDAQ) - Page 5 | MetaTrader

Abrir gráfico completo

Visão geral Todos os ativos Mapa de calor

Principais ativos Market Value Shares Weight %

SRPT Sarepta Therapeutics, Inc. 16.1 M 739.6 K 0.2%

CAI Caris Life Sciences, Inc. 16.1 M 898.0 K 0.2%

IMVT Immunovant, Inc. 15.6 M 626.2 K 0.2%

ADMA ADMA Biologics, Inc. 15.4 M 1.7 M 0.2%

ADPT Adaptive Biotechnologies Corp. 15.4 M 1.1 M 0.2%

SMMT Summit Therapeutics, Inc. 15.2 M 799.5 K 0.2%

ORKA Oruka Therapeutics, Inc. 14.9 M 304.3 K 0.2%

SNDX Syndax Pharmaceuticals, Inc. 14.8 M 631.5 K 0.2%

TNGX Tango Therapeutics, Inc. 14.4 M 687.9 K 0.2%

RARE Ultragenyx Pharmaceutical, Inc. 14.3 M 680.3 K 0.2%

IRON Disc Medicine, Inc. 13.7 M 214.9 K 0.2%

AGIO Agios Pharmaceuticals, Inc. 13.5 M 400.1 K 0.2%

GRAL GRAIL, Inc. 13.5 M 261.0 K 0.2%

DFTX Definium Therapeutics, Inc. 13.3 M 703.0 K 0.2%

ZYME Zymeworks, Inc. 13.3 M 530.0 K 0.2%

RCUS Arcus Biosciences, Inc. 13.2 M 612.4 K 0.2%

AUPH Aurinia Pharmaceuticals, Inc. 13.0 M 874.3 K 0.2%

ELVN Enliven Therapeutics, Inc. 12.6 M 322.6 K 0.2%

Day One Biopharmaceuticals, Inc. 12.4 M 578.8 K 0.2%

VCEL Vericel Corp. 12.0 M 373.5 K 0.1%

1
2
3
4
5
6
7
8
...
13

Notícias

UBS lista 5 motivos principais pelos quais ações de biotecnologia de médio porte devem se destacar em 2026